Leprosy Mailing List – July 16, 2025
Ref.: (LML) Outcome International Leprosy Congress. Bali. July 2025
From: Pieter AM Schreuder, Maastricht, the Netherlands
Dear Colleagues,
Several of the LML readers participated in the Bali congress. It would be interesting if they would share their experiences or observations with the rest of us. May be their own presentation, or what was new to them, or what they took home to apply in their own project.
There must have been for example some heated discussions about so-called 'relapsed' reversal reactions: real relapses or the patients have not been treated with the right doses of steroids for a long enough period of time? Are there already preliminary results of the Methotrexate for ENL study? Does PEP cause an increase in impairments in newly diagnosed patients? New drug schedules? Life-long treatment for LL patients? Etc., etc.
Best regards,
Pieter AM Schreuder
_______________________________________________________________________________
LML - S Deepak, B Naafs, S Noto and P Schreuder
LML blog link: http://leprosymailinglist.blogspot.it/
Contact: Dr Pieter Schreuder << editorlml@gmail.com
You received this message because you are subscribed to the Google Groups "Leprosy Mailing List" group.
To unsubscribe from this group and stop receiving emails from it, send an email to leprosymailinglist+unsubscribe@googlegroups.com.
To view this discussion visit https://groups.google.com/d/msgid/leprosymailinglist/6b8d9bed-e3c1-449e-aadf-5ca50119b6efn%40googlegroups.com.
No comments:
Post a Comment